Christopher Carlin, MB ChB, PhD, explores the potential of AI-driven insights to enhance COPD care and identify candidates for biologic therapy.

Starting January 1, 2026, the Centers for Medicare and Medicaid Services (CMS) will introduce a new pilot prior authorization program in select states. Here’s what you should know about how it could ...